1. Home
  2. LASR vs VERA Comparison

LASR vs VERA Comparison

Compare LASR & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

HOLD

Current Price

$78.86

Market Cap

4.0B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$36.39

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASR
VERA
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.2B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
LASR
VERA
Price
$78.86
$36.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
10
Target Price
$54.31
$81.30
AVG Volume (30 Days)
1.1M
954.9K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
62.99
N/A
EPS
0.01
N/A
Revenue
$191,359,000.00
N/A
Revenue This Year
$10.91
N/A
Revenue Next Year
$14.32
$472.48
P/E Ratio
$8,408.00
N/A
Revenue Growth
38.09
N/A
52 Week Low
$12.17
$18.76
52 Week High
$86.95
$56.05

Technical Indicators

Market Signals
Indicator
LASR
VERA
Relative Strength Index (RSI) 59.61 41.92
Support Level $53.33 $34.04
Resistance Level $80.27 $42.77
Average True Range (ATR) 6.08 1.86
MACD 0.89 -0.01
Stochastic Oscillator 64.43 35.24

Price Performance

Historical Comparison
LASR
VERA

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: